Allient price target lowered to $28 from $39 at Roth MKM

Roth MKM lowered the firm’s price target on Allient to $28 from $39 but keeps a Buy rating on the shares after its Q2 earnings miss. The firm is seeing headwinds across the company’s end markets, though it also believes that Allient will be addressing these issues quickly with integration and restructuring efforts which have already taken $5M out of costs, the analyst tells investors in a research note.